TWI697560B - 用於偵測細菌污染之方法及組合物 - Google Patents
用於偵測細菌污染之方法及組合物 Download PDFInfo
- Publication number
- TWI697560B TWI697560B TW103125440A TW103125440A TWI697560B TW I697560 B TWI697560 B TW I697560B TW 103125440 A TW103125440 A TW 103125440A TW 103125440 A TW103125440 A TW 103125440A TW I697560 B TWI697560 B TW I697560B
- Authority
- TW
- Taiwan
- Prior art keywords
- seq
- primer
- sequence
- complement
- probe
- Prior art date
Links
- 230000001580 bacterial effect Effects 0.000 title claims abstract description 210
- 238000000034 method Methods 0.000 title claims abstract description 157
- 238000011109 contamination Methods 0.000 title claims abstract description 94
- 239000000203 mixture Substances 0.000 title claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 185
- 239000000523 sample Substances 0.000 claims description 450
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 252
- 230000003321 amplification Effects 0.000 claims description 250
- 150000007523 nucleic acids Chemical class 0.000 claims description 139
- 102000039446 nucleic acids Human genes 0.000 claims description 126
- 108020004707 nucleic acids Proteins 0.000 claims description 126
- 108091093088 Amplicon Proteins 0.000 claims description 117
- 230000000295 complement effect Effects 0.000 claims description 108
- 125000003729 nucleotide group Chemical group 0.000 claims description 96
- 239000002773 nucleotide Substances 0.000 claims description 92
- 238000001514 detection method Methods 0.000 claims description 89
- 241000894007 species Species 0.000 claims description 76
- 108091033319 polynucleotide Proteins 0.000 claims description 62
- 102000040430 polynucleotide Human genes 0.000 claims description 62
- 239000002157 polynucleotide Substances 0.000 claims description 62
- 108020004465 16S ribosomal RNA Proteins 0.000 claims description 57
- 238000009396 hybridization Methods 0.000 claims description 52
- 239000011541 reaction mixture Substances 0.000 claims description 51
- 241000894006 Bacteria Species 0.000 claims description 43
- 108091036078 conserved sequence Proteins 0.000 claims description 31
- 238000003752 polymerase chain reaction Methods 0.000 claims description 28
- 239000012472 biological sample Substances 0.000 claims description 21
- 102000004190 Enzymes Human genes 0.000 claims description 17
- 108090000790 Enzymes Proteins 0.000 claims description 17
- 210000004027 cell Anatomy 0.000 claims description 15
- 239000003634 thrombocyte concentrate Substances 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- 108020004414 DNA Proteins 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- 241000186429 Propionibacterium Species 0.000 claims description 10
- 241000191940 Staphylococcus Species 0.000 claims description 10
- 239000011324 bead Substances 0.000 claims description 10
- 238000013518 transcription Methods 0.000 claims description 10
- 230000035897 transcription Effects 0.000 claims description 10
- 241000192125 Firmicutes Species 0.000 claims description 9
- 230000001404 mediated effect Effects 0.000 claims description 9
- 239000013642 negative control Substances 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 9
- 210000000601 blood cell Anatomy 0.000 claims description 8
- 238000011901 isothermal amplification Methods 0.000 claims description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 7
- 230000004544 DNA amplification Effects 0.000 claims description 7
- 230000004568 DNA-binding Effects 0.000 claims description 7
- 238000006073 displacement reaction Methods 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 6
- 238000007834 ligase chain reaction Methods 0.000 claims description 6
- 238000005096 rolling process Methods 0.000 claims description 6
- 239000007790 solid phase Substances 0.000 claims description 6
- 241000588923 Citrobacter Species 0.000 claims description 5
- 241000589516 Pseudomonas Species 0.000 claims description 5
- 241000194017 Streptococcus Species 0.000 claims description 4
- 230000001332 colony forming effect Effects 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 241000193403 Clostridium Species 0.000 claims 3
- 241000588914 Enterobacter Species 0.000 claims 3
- 241000194033 Enterococcus Species 0.000 claims 3
- 241000588722 Escherichia Species 0.000 claims 3
- 241000186660 Lactobacillus Species 0.000 claims 3
- 241000186781 Listeria Species 0.000 claims 3
- 241000192041 Micrococcus Species 0.000 claims 3
- 241000607720 Serratia Species 0.000 claims 3
- 241000607734 Yersinia <bacteria> Species 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 229940039696 lactobacillus Drugs 0.000 claims 3
- 241000588748 Klebsiella Species 0.000 claims 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000013615 primer Substances 0.000 description 357
- 210000004369 blood Anatomy 0.000 description 34
- 241000191967 Staphylococcus aureus Species 0.000 description 33
- 239000008280 blood Substances 0.000 description 33
- 239000000047 product Substances 0.000 description 33
- 239000002987 primer (paints) Substances 0.000 description 31
- 238000003753 real-time PCR Methods 0.000 description 27
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 25
- 241000588724 Escherichia coli Species 0.000 description 21
- 230000035945 sensitivity Effects 0.000 description 17
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 16
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 16
- 108090000623 proteins and genes Proteins 0.000 description 16
- 108091034117 Oligonucleotide Proteins 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 238000004458 analytical method Methods 0.000 description 14
- 239000012530 fluid Substances 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- 102100034343 Integrase Human genes 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 11
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 11
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 210000002381 plasma Anatomy 0.000 description 10
- -1 plastid Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 238000004891 communication Methods 0.000 description 9
- 230000000670 limiting effect Effects 0.000 description 9
- 230000002441 reversible effect Effects 0.000 description 9
- 235000012431 wafers Nutrition 0.000 description 9
- 241000193755 Bacillus cereus Species 0.000 description 8
- 108010042407 Endonucleases Proteins 0.000 description 8
- 241000186779 Listeria monocytogenes Species 0.000 description 8
- 241000607715 Serratia marcescens Species 0.000 description 8
- 241000191963 Staphylococcus epidermidis Species 0.000 description 8
- 241000193985 Streptococcus agalactiae Species 0.000 description 8
- 241000193998 Streptococcus pneumoniae Species 0.000 description 8
- 241000193996 Streptococcus pyogenes Species 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 229940115931 listeria monocytogenes Drugs 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108020000946 Bacterial DNA Proteins 0.000 description 7
- 241000193468 Clostridium perfringens Species 0.000 description 7
- 102100031780 Endonuclease Human genes 0.000 description 7
- 241000588747 Klebsiella pneumoniae Species 0.000 description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 description 7
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 7
- 241000191938 Micrococcus luteus Species 0.000 description 7
- 238000002869 basic local alignment search tool Methods 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 7
- 108020004999 messenger RNA Proteins 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 7
- 102000053602 DNA Human genes 0.000 description 6
- 241000194032 Enterococcus faecalis Species 0.000 description 6
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 6
- 108700008625 Reporter Genes Proteins 0.000 description 6
- 206010040047 Sepsis Diseases 0.000 description 6
- 238000000137 annealing Methods 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000000306 component Substances 0.000 description 6
- 238000004925 denaturation Methods 0.000 description 6
- 230000036425 denaturation Effects 0.000 description 6
- 229940032049 enterococcus faecalis Drugs 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 108020004635 Complementary DNA Proteins 0.000 description 5
- 241000588915 Klebsiella aerogenes Species 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 5
- 230000000692 anti-sense effect Effects 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000012503 blood component Substances 0.000 description 5
- 238000010804 cDNA synthesis Methods 0.000 description 5
- 239000002299 complementary DNA Substances 0.000 description 5
- 229940092559 enterobacter aerogenes Drugs 0.000 description 5
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 229940045505 klebsiella pneumoniae Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 4
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
- 241000235013 Yarrowia Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000003278 mimic effect Effects 0.000 description 4
- 239000002751 oligonucleotide probe Substances 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- 239000004055 small Interfering RNA Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- 241000588917 Citrobacter koseri Species 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 101710203526 Integrase Proteins 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 3
- 108700011259 MicroRNAs Proteins 0.000 description 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 102000006382 Ribonucleases Human genes 0.000 description 3
- 108010083644 Ribonucleases Proteins 0.000 description 3
- 108091028664 Ribonucleotide Proteins 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 239000002336 ribonucleotide Substances 0.000 description 3
- 238000002864 sequence alignment Methods 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 108010068698 spleen exonuclease Proteins 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000001226 triphosphate Substances 0.000 description 3
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 2
- SJQRQOKXQKVJGJ-UHFFFAOYSA-N 5-(2-aminoethylamino)naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1S(O)(=O)=O SJQRQOKXQKVJGJ-UHFFFAOYSA-N 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 241001464975 Cutibacterium granulosum Species 0.000 description 2
- 108010017826 DNA Polymerase I Proteins 0.000 description 2
- 102000004594 DNA Polymerase I Human genes 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 102100026816 DNA-dependent metalloprotease SPRTN Human genes 0.000 description 2
- 101710175461 DNA-dependent metalloprotease SPRTN Proteins 0.000 description 2
- 241001272567 Hominoidea Species 0.000 description 2
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 2
- 238000007397 LAMP assay Methods 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 2
- 241001521757 Propionibacterium sp. Species 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 108091027967 Small hairpin RNA Proteins 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 101710137500 T7 RNA polymerase Proteins 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- 108010001244 Tli polymerase Proteins 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 241000607447 Yersinia enterocolitica Species 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000959 cryoprotective effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- CTSPAMFJBXKSOY-UHFFFAOYSA-N ellipticine Chemical compound N1=CC=C2C(C)=C(NC=3C4=CC=CC=3)C4=C(C)C2=C1 CTSPAMFJBXKSOY-UHFFFAOYSA-N 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 238000011880 melting curve analysis Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000001821 nucleic acid purification Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229960000286 proflavine Drugs 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 108700022487 rRNA Genes Proteins 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
- 229940045145 uridine Drugs 0.000 description 2
- 229940098232 yersinia enterocolitica Drugs 0.000 description 2
- WHTVZRBIWZFKQO-AWEZNQCLSA-N (S)-chloroquine Chemical compound ClC1=CC=C2C(N[C@@H](C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-AWEZNQCLSA-N 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108020004463 18S ribosomal RNA Proteins 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- NGYHUCPPLJOZIX-XLPZGREQSA-N 5-methyl-dCTP Chemical compound O=C1N=C(N)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NGYHUCPPLJOZIX-XLPZGREQSA-N 0.000 description 1
- 108020004565 5.8S Ribosomal RNA Proteins 0.000 description 1
- 108020005075 5S Ribosomal RNA Proteins 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 108091028026 C-DNA Proteins 0.000 description 1
- 101150018198 COX1 gene Proteins 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 108091092236 Chimeric RNA Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186249 Corynebacterium sp. Species 0.000 description 1
- 241001289635 Curetis Species 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 108050009160 DNA polymerase 1 Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- WEAHRLBPCANXCN-UHFFFAOYSA-N Daunomycin Natural products CCC1(O)CC(OC2CC(N)C(O)C(C)O2)c3cc4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1 WEAHRLBPCANXCN-UHFFFAOYSA-N 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000701832 Enterobacteria phage T3 Species 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- ZIXGXMMUKPLXBB-UHFFFAOYSA-N Guatambuinine Natural products N1C2=CC=CC=C2C2=C1C(C)=C1C=CN=C(C)C1=C2 ZIXGXMMUKPLXBB-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 241000191953 Kocuria varians Species 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 108700036248 MT-RNR1 Proteins 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 206010051141 Myeloblastoma Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 108010019653 Pwo polymerase Proteins 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- SUYXJDLXGFPMCQ-INIZCTEOSA-N SJ000287331 Natural products CC1=c2cnccc2=C(C)C2=Nc3ccccc3[C@H]12 SUYXJDLXGFPMCQ-INIZCTEOSA-N 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000191978 Staphylococcus simulans Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- VGQOVCHZGQWAOI-UHFFFAOYSA-N UNPD55612 Natural products N1C(O)C2CC(C=CC(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- CCPIKNHZOWQALM-DLQJRSQOSA-N [[(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphinothioyl] phosphono hydrogen phosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=S)OP(O)(=O)OP(O)(O)=O)O1 CCPIKNHZOWQALM-DLQJRSQOSA-N 0.000 description 1
- DLLXAZJTLIUPAI-UHFFFAOYSA-N [[5-(2-amino-4-oxo-1h-pyrrolo[2,3-d]pyrimidin-7-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2C=CN1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 DLLXAZJTLIUPAI-UHFFFAOYSA-N 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- DPKHZNPWBDQZCN-UHFFFAOYSA-N acridine orange free base Chemical compound C1=CC(N(C)C)=CC2=NC3=CC(N(C)C)=CC=C3C=C21 DPKHZNPWBDQZCN-UHFFFAOYSA-N 0.000 description 1
- 229940023020 acriflavine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- VGQOVCHZGQWAOI-HYUHUPJXSA-N anthramycin Chemical compound N1[C@@H](O)[C@@H]2CC(\C=C\C(N)=O)=CN2C(=O)C2=CC=C(C)C(O)=C12 VGQOVCHZGQWAOI-HYUHUPJXSA-N 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003677 chloroquine Drugs 0.000 description 1
- WHTVZRBIWZFKQO-UHFFFAOYSA-N chloroquine Natural products ClC1=CC=C2C(NC(C)CCCN(CC)CC)=CC=NC2=C1 WHTVZRBIWZFKQO-UHFFFAOYSA-N 0.000 description 1
- ZYVSOIYQKUDENJ-WKSBCEQHSA-N chromomycin A3 Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@@H]1OC(C)=O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@@H]1C[C@@H](O)[C@@H](OC)[C@@H](C)O1 ZYVSOIYQKUDENJ-WKSBCEQHSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- CFCUWKMKBJTWLW-UHFFFAOYSA-N deoliosyl-3C-alpha-L-digitoxosyl-MTM Natural products CC=1C(O)=C2C(O)=C3C(=O)C(OC4OC(C)C(O)C(OC5OC(C)C(O)C(OC6OC(C)C(O)C(C)(O)C6)C5)C4)C(C(OC)C(=O)C(O)C(C)O)CC3=CC2=CC=1OC(OC(C)C1O)CC1OC1CC(O)C(O)C(C)O1 CFCUWKMKBJTWLW-UHFFFAOYSA-N 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-O diazynium Chemical compound [NH+]#N IJGRMHOSHXDMSA-UHFFFAOYSA-O 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 208000010227 enterocolitis Diseases 0.000 description 1
- 230000006862 enzymatic digestion Effects 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000004023 fresh frozen plasma Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 101150055609 fusA gene Proteins 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000013412 genome amplification Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 101150013736 gyrB gene Proteins 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000001006 meconium Anatomy 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- CFCUWKMKBJTWLW-BKHRDMLASA-N mithramycin Chemical compound O([C@@H]1C[C@@H](O[C@H](C)[C@H]1O)OC=1C=C2C=C3C[C@H]([C@@H](C(=O)C3=C(O)C2=C(O)C=1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](O[C@@H]2O[C@H](C)[C@H](O)[C@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@@](C)(O)C3)C2)C1)[C@H](OC)C(=O)[C@@H](O)[C@@H](C)O)[C@H]1C[C@@H](O)[C@H](O)[C@@H](C)O1 CFCUWKMKBJTWLW-BKHRDMLASA-N 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- UPBAOYRENQEPJO-UHFFFAOYSA-N n-[5-[[5-[(3-amino-3-iminopropyl)carbamoyl]-1-methylpyrrol-3-yl]carbamoyl]-1-methylpyrrol-3-yl]-4-formamido-1-methylpyrrole-2-carboxamide Chemical compound CN1C=C(NC=O)C=C1C(=O)NC1=CN(C)C(C(=O)NC2=CN(C)C(C(=O)NCCC(N)=N)=C2)=C1 UPBAOYRENQEPJO-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000002071 nanotube Substances 0.000 description 1
- 239000002070 nanowire Substances 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 101150101270 nifD gene Proteins 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- 239000005304 optical glass Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229960003171 plicamycin Drugs 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 101150079601 recA gene Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001044 red dye Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 101150090202 rpoB gene Proteins 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 108010042747 stallimycin Proteins 0.000 description 1
- 229940037648 staphylococcus simulans Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/15—Modifications characterised by incorporating a consensus or conserved sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361858495P | 2013-07-25 | 2013-07-25 | |
| US61/858,495 | 2013-07-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201525145A TW201525145A (zh) | 2015-07-01 |
| TWI697560B true TWI697560B (zh) | 2020-07-01 |
Family
ID=52393976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW103125440A TWI697560B (zh) | 2013-07-25 | 2014-07-24 | 用於偵測細菌污染之方法及組合物 |
Country Status (11)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12529106B2 (en) | 2023-06-09 | 2026-01-20 | Inti Taiwan, Inc. | Assays and methods to assist in vitro fertilization |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015013465A2 (en) | 2013-07-25 | 2015-01-29 | Dch Molecular Diagnostics, Inc. | Methods and compositions for detecting bacterial contamination |
| US20160244812A1 (en) * | 2013-10-07 | 2016-08-25 | Mitsui Chemicals, Inc. | Primer set for pcr for bacterial dna amplification, kit for detection and/or identification of bacterial species, and, method of detection and/or identification of bacterial species |
| US9953415B2 (en) * | 2014-12-03 | 2018-04-24 | Tata Consultancy Services Limited | System and method for quantification of Escherichia coli bacteria in water |
| CA2995468A1 (en) * | 2015-08-12 | 2017-02-16 | Circulogene Theranostics, Llc | Method of preparing cell free nucleic acid molecules by in situ amplification |
| CN105368961A (zh) * | 2015-12-15 | 2016-03-02 | 天津脉络生物科技有限公司 | 一种沙雷菌定量检测荧光pcr试剂盒及其应用 |
| KR102326769B1 (ko) * | 2016-03-25 | 2021-11-17 | 카리우스, 인코포레이티드 | 합성 핵산 스파이크-인 |
| CN105734164B (zh) * | 2016-05-06 | 2019-05-17 | 苏州大学 | 一种检测细菌性脑膜炎病原体的多重pcr试剂盒 |
| CN106434890B (zh) * | 2016-08-30 | 2020-02-21 | 上海生物信息技术研究中心 | 快速恒温检测小肠结肠炎耶尔森氏菌的方法、引物及试剂盒 |
| US20190062809A1 (en) * | 2017-08-24 | 2019-02-28 | Clinical Micro Sensors, Inc. (dba GenMark Diagnostics, Inc.) | Electrochemical detection of bacterial and/or fungal infections |
| EP3706574A4 (en) * | 2017-11-06 | 2021-08-25 | The Regents of The University of Michigan | COMPOSITIONS AND METHODS FOR DETECTION OF MICRO-ORGANISMS |
| JP2021502825A (ja) * | 2017-11-13 | 2021-02-04 | ライフ テクノロジーズ コーポレイション | 尿路微生物検出のための組成物、方法、およびキット |
| US12291745B2 (en) * | 2018-01-30 | 2025-05-06 | Biofire Defense, Llc | Methods and systems for validation of a nucleic acid amplification assay |
| CN108148834B (zh) * | 2018-03-14 | 2018-11-13 | 北京理工大学 | 用于检测空间环境中的真菌的引物组合、试剂盒及方法 |
| WO2019200134A2 (en) * | 2018-04-13 | 2019-10-17 | National Agricultural Genotyping Center | Universal lactic acid bacteria quantification kits, methods, compositions and apparatuses therefor |
| US11473133B2 (en) * | 2018-09-24 | 2022-10-18 | Second Genome, Inc. | Methods for validation of microbiome sequence processing and differential abundance analyses via multiple bespoke spike-in mixtures |
| CN109337967A (zh) * | 2018-09-27 | 2019-02-15 | 华中科技大学鄂州工业技术研究院 | 一种实验室的微生物污染鉴别方法 |
| FR3097560B1 (fr) * | 2019-06-24 | 2021-06-25 | Oreal | Méthode de diagnostic d’une exposition chronique à la pollution |
| CN111209895B (zh) * | 2020-02-14 | 2022-03-25 | 李淑媛 | 静脉药物配制样品的细菌污染检测系统、方法及存储介质 |
| CN112575097B (zh) * | 2020-10-12 | 2022-05-10 | 南开大学 | 一种用于检测蜡样芽孢杆菌的液相芯片及应用 |
| WO2022081815A1 (en) * | 2020-10-14 | 2022-04-21 | Pickens Peter Vincent | Optimized detection of blood-borne microbes |
| JP7553323B2 (ja) | 2020-10-30 | 2024-09-18 | 株式会社Kri | スタフィロコッカス細菌の同定方法 |
| CN112226528B (zh) * | 2020-12-14 | 2021-03-16 | 臻和(北京)生物科技有限公司 | 一种用于生物组织样本检测细菌污染的质检方法 |
| CN116745434A (zh) * | 2021-01-20 | 2023-09-12 | 保障生物系统控股有限公司 | 基因组序列的改进的检测及其探针分子 |
| WO2023034618A1 (en) * | 2021-09-03 | 2023-03-09 | Micronoma, Inc. | Methods of identifying cancer-associated microbial biomarkers |
| CN114480596A (zh) * | 2022-02-11 | 2022-05-13 | 宁波市中心血站 | 一种微流控血液及血制品细菌污染检测方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0692540A2 (en) * | 1994-06-17 | 1996-01-17 | Becton, Dickinson and Company | Oligonucleotide primers and probes for detection of bacteria |
| WO2002010444A1 (en) | 2000-07-28 | 2002-02-07 | University Of Sydney | A method of detecting microorganisms |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322770A (en) | 1989-12-22 | 1994-06-21 | Hoffman-Laroche Inc. | Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription |
| US5310652A (en) | 1986-08-22 | 1994-05-10 | Hoffman-La Roche Inc. | Reverse transcription with thermostable DNA polymerase-high temperature reverse transcription |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| US5130238A (en) | 1988-06-24 | 1992-07-14 | Cangene Corporation | Enhanced nucleic acid amplification process |
| US5234809A (en) | 1989-03-23 | 1993-08-10 | Akzo N.V. | Process for isolating nucleic acid |
| WO1991001384A1 (en) | 1989-07-11 | 1991-02-07 | Gen-Probe, Incorporated | Nucleic acid sequence amplification methods utilizing a transcription complex |
| CA2020958C (en) | 1989-07-11 | 2005-01-11 | Daniel L. Kacian | Nucleic acid sequence amplification methods |
| US5494810A (en) | 1990-05-03 | 1996-02-27 | Cornell Research Foundation, Inc. | Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5455166A (en) | 1991-01-31 | 1995-10-03 | Becton, Dickinson And Company | Strand displacement amplification |
| US5994056A (en) | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| US5270184A (en) | 1991-11-19 | 1993-12-14 | Becton, Dickinson And Company | Nucleic acid target generation |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| EP0728218B1 (en) | 1993-11-12 | 2008-01-02 | PHRI Properties, Inc. | Hybridization probes for nucleic acid detection, universal stems, methods and kits |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
| US5641658A (en) | 1994-08-03 | 1997-06-24 | Mosaic Technologies, Inc. | Method for performing amplification of nucleic acid with two primers bound to a single solid support |
| US5705628A (en) | 1994-09-20 | 1998-01-06 | Whitehead Institute For Biomedical Research | DNA purification and isolation using magnetic particles |
| US5705365A (en) | 1995-06-07 | 1998-01-06 | Gen-Probe Incorporated | Kits for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product |
| US5710029A (en) | 1995-06-07 | 1998-01-20 | Gen-Probe Incorporated | Methods for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| AU713667B2 (en) | 1996-04-12 | 1999-12-09 | Phri Properties, Inc. | Detection probes, kits and assays |
| US20100267012A1 (en) * | 1997-11-04 | 2010-10-21 | Bergeron Michel G | Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| EP2327797B1 (en) | 1997-04-01 | 2015-11-25 | Illumina Cambridge Limited | Method of nucleic acid sequencing |
| AU9220498A (en) | 1997-09-04 | 1999-03-22 | Bayer Corporation | Oligonucleotide probes bearing quenchable fluorescent labels, and methods of usethereof |
| AR021833A1 (es) | 1998-09-30 | 2002-08-07 | Applied Research Systems | Metodos de amplificacion y secuenciacion de acido nucleico |
| EP1020534B2 (en) | 1998-11-09 | 2011-01-05 | Eiken Kagaku Kabushiki Kaisha | Process for synthesizing nucleic acid |
| ATE262595T1 (de) | 1999-09-13 | 2004-04-15 | Nugen Technologies Inc | Methoden und zusammensetzungen zur linearen isothermalen amplifikation von polynukleotidsequenzen |
| CA2937907C (en) * | 1999-09-28 | 2017-08-22 | Geneohm Sciences Canada Inc. | Nucleic acids, methods and kits for the detection of campylobacter |
| US7019129B1 (en) | 2000-05-09 | 2006-03-28 | Biosearch Technologies, Inc. | Dark quenchers for donor-acceptor energy transfer |
| US7001724B1 (en) | 2000-11-28 | 2006-02-21 | Applera Corporation | Compositions, methods, and kits for isolating nucleic acids using surfactants and proteases |
| AU2003272438B2 (en) | 2002-09-20 | 2009-04-02 | New England Biolabs, Inc. | Helicase dependent amplification of nucleic acids |
| EP1565576A2 (en) | 2002-11-20 | 2005-08-24 | Pharmacia Italia S.p.A. | Method for the detection of microorganisms in pharmaceutical products |
| CA2508720A1 (en) | 2002-12-03 | 2004-06-17 | Dartmouth College | Method to measure a t cell response and its uses to qualify antigen-presenting cells |
| EP1473370A3 (en) * | 2003-04-24 | 2005-03-09 | BioMerieux, Inc. | Genus, group, species and/or strain specific 16S rDNA Sequences |
| CA2562221A1 (en) * | 2005-10-21 | 2007-04-21 | Canadian Blood Services | A method for detection of staphylococcus epidermidis |
| JP2010524454A (ja) | 2007-04-19 | 2010-07-22 | モレキュラー ディテクション インコーポレーテッド | 抗生物質耐性細菌の検出および分析のための方法、組成物、およびキット |
| BR112012009023A2 (pt) * | 2009-10-22 | 2019-09-24 | Biotools Biotechnologial & Medical Laboratories S A | método pra detecção. diferenciação e identificação de eubactérias específica de táxons em uma amostra biológica por meio de técnicas de análise de sequenciamento e kit |
| WO2012071135A2 (en) | 2010-11-23 | 2012-05-31 | Biovec Transfusion, Llc | Methods for removing pathogens from a platelet preparation |
| WO2015013465A2 (en) | 2013-07-25 | 2015-01-29 | Dch Molecular Diagnostics, Inc. | Methods and compositions for detecting bacterial contamination |
-
2014
- 2014-07-23 WO PCT/US2014/047914 patent/WO2015013465A2/en not_active Ceased
- 2014-07-23 CN CN201480041899.XA patent/CN105473737B/zh active Active
- 2014-07-23 CA CA2917430A patent/CA2917430C/en active Active
- 2014-07-23 KR KR1020167002201A patent/KR102245110B1/ko active Active
- 2014-07-23 US US14/900,260 patent/US10392670B2/en active Active
- 2014-07-23 MX MX2016000997A patent/MX2016000997A/es unknown
- 2014-07-23 CN CN201910931743.3A patent/CN110592244A/zh active Pending
- 2014-07-23 AU AU2014293075A patent/AU2014293075A1/en not_active Abandoned
- 2014-07-23 JP JP2016529875A patent/JP2016525359A/ja not_active Withdrawn
- 2014-07-23 EP EP14829096.8A patent/EP3024947B1/en active Active
- 2014-07-23 SG SG11201600550WA patent/SG11201600550WA/en unknown
- 2014-07-24 TW TW103125440A patent/TWI697560B/zh not_active IP Right Cessation
-
2019
- 2019-06-20 JP JP2019114426A patent/JP2019187431A/ja active Pending
- 2019-07-02 US US16/460,536 patent/US11274351B2/en not_active Expired - Fee Related
-
2021
- 2021-09-27 JP JP2021156674A patent/JP2022023068A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0692540A2 (en) * | 1994-06-17 | 1996-01-17 | Becton, Dickinson and Company | Oligonucleotide primers and probes for detection of bacteria |
| WO2002010444A1 (en) | 2000-07-28 | 2002-02-07 | University Of Sydney | A method of detecting microorganisms |
Non-Patent Citations (7)
| Title |
|---|
| Dergousoff SJ, Chilton NB, Association of Different Genetic Types of Francisella-Like Organisms with the Rocky Mountain Wood Tick (Dermacentor andersoni) and the American Dog Tick (Dermacentor variabilis) in Localities Near Their Northern Distributional Limits Appl Environ Microbiol. 2012 Feb; 78(4): 965–971. * |
| Ishaq SL, Wright ADG, Insight into the bacterial gut microbiome of the North American moose (Alces alces). BMC Microbiol. 2012; 12: 212. * |
| Ishaq SL, Wright ADG, Insight into the bacterial gut microbiome of the North American moose (Alces alces). BMC Microbiol. 2012; 12: 212. ^&rn^ |
| Jakobsson T, Forsum U, Changes in the predominant human Lactobacillus flora during in vitro fertilization. Ann Clin Microbiol Antimicrob. 2008; 7: 14. * |
| Jakobsson T, Forsum U, Changes in the predominant human Lactobacillus flora during in vitro fertilization. Ann Clin Microbiol Antimicrob. 2008; 7: 14. ^&rn^ |
| Kajiwara H, Toda M, Mine T, Nakada H, Yamamoto T, Isolation of Fucosyltransferase-Producing Bacteria from Marine Environments. Microbes Environ. 2012 Dec; 27(4): 515–518. * |
| Mohammadi T, Pietersz RN, Vandenbroucke-Grauls CM, Savelkoul PH, Reesink HW. Detection of bacteria in platelet concentrates: comparison of broad-range real-time 16S rDNA polymerase chain reaction and automated culturing. Transfusion. 2005 May; 45(5): 731-6. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12529106B2 (en) | 2023-06-09 | 2026-01-20 | Inti Taiwan, Inc. | Assays and methods to assist in vitro fertilization |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2016525359A (ja) | 2016-08-25 |
| WO2015013465A2 (en) | 2015-01-29 |
| EP3024947B1 (en) | 2020-10-28 |
| CN110592244A (zh) | 2019-12-20 |
| EP3024947A4 (en) | 2017-03-15 |
| SG11201600550WA (en) | 2016-02-26 |
| KR102245110B1 (ko) | 2021-04-27 |
| AU2014293075A1 (en) | 2015-12-17 |
| CA2917430A1 (en) | 2015-01-29 |
| MX2016000997A (es) | 2016-04-19 |
| US10392670B2 (en) | 2019-08-27 |
| CN105473737A (zh) | 2016-04-06 |
| WO2015013465A3 (en) | 2015-04-23 |
| US20200080134A1 (en) | 2020-03-12 |
| US11274351B2 (en) | 2022-03-15 |
| JP2022023068A (ja) | 2022-02-07 |
| KR20160034318A (ko) | 2016-03-29 |
| CN105473737B (zh) | 2019-10-25 |
| US20160355871A1 (en) | 2016-12-08 |
| EP3024947A2 (en) | 2016-06-01 |
| TW201525145A (zh) | 2015-07-01 |
| HK1219298A1 (en) | 2017-03-31 |
| CA2917430C (en) | 2020-10-06 |
| JP2019187431A (ja) | 2019-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11274351B2 (en) | Methods and compositions for detecting bacterial contamination | |
| US20240175099A1 (en) | Direct amplification and detection of viral and bacterial pathogens | |
| JP2018500926A (ja) | 薬剤に対する生物の応答のマイクロ流体測定 | |
| TW201728759A (zh) | 核酸擴增方法和系統 | |
| CN101611155B (zh) | 虾病原体诊断用序列 | |
| US20160348189A1 (en) | Molecular detection of rna | |
| Hassan et al. | Loop-mediated isothermal amplification (LAMP): Comparative advances over conventional PCR and other molecular techniques | |
| JP2014519822A (ja) | スタフィロコッカス・アウレウスの検出のための組成物及び方法 | |
| Zhang et al. | Rapid and simple detection of Listeria monocytogenes using real closed dumbbell-mediated isothermal amplification | |
| HK1219298B (en) | Methods and compositions for detecting bacterial contamination | |
| HK40082755A (en) | Direct amplification and detection of viral and bacterial pathogens | |
| HK1259935A1 (en) | Methods and systems for nucleic acid amplification |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |